Please note: Dr. Sale is no longer accepting 2020 summer student applications.
Dr. Joanna Sale is a clinical epidemiologist whose current interests are in evidence-to-care gaps in musculoskeletal conditions, the patient perspective, medication use, older adults with multiple chronic diseases, and behaviour change. She co-leads the evaluation of the provincial Fracture Screening and Prevention Program, a program within the Ontario Osteoporosis Strategy that is funded by the Ontario Ministry of Health and Long-Term Care. While Sale’s main area of research is in bone health (patients with osteoporotic or fragility fractures), she is also involved in projects related to pain, osteoarthritis, rheumatoid arthritis, diabetes, mental health, asthma, kidney disease, and caregiving.
Dr. Sale’s program of research includes studies that examine topics such as patients’ understanding of risk, how patients navigate the health care system, patients’ experience of the clinical encounter, and how patients manage their health condition in a real world setting. She specializes in primary data collection.
Dr. Sale received her Masters of Science degree from the University of British Columbia, her PhD from McMaster University, and her Post-Doctorate from the University of Toronto.
Selected Recent Publications
1. Sale JEM, Marwah A, Naeem F, Yu W, Meadows L. Evidence of patient beliefs, values and preferences is not provided in osteoporosis clinical practice guidelines. Osteoporosis International 2019, in press.
2. Sale JEM, Gray M, Mancuso D, Inrig T, Boire G, Beaulieu M-C, Funnell L, Bogoch E. Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelines. Rheumatology International 2018;38(12):2193-2208.
3. Sale JEM, Thielke S. Qualitative research is a fundamental scientific process. Journal of Clinical Epidemiology 2018;102:129-133.
4. Gupta S, Cheung VLS, Kastner M, Straus S, Kaplan A, Boulet L-P, Sale JEM. Patient preferences for a touch screen tablet-based asthma questionnaire. Journal of Asthma 2018;28:1-11.
5. Gheorghita A, Webster F, Thielke S, Sale JEM. Long-term experiences of pain after a fragility fracture. Osteoporosis International 2018;29:1093-1104.
6. Sale JEM, Frankel L, Thielke S, Funnell L. Pain and fracture-related limitations persist beyond six months after a fragility fracture. Rheumatology International 2017;37(8):1317-1322.
7. Sale JEM, Cameron C, Thielke S, Meadows L, Senior K. The theory of planned behavior explains intentions to use antiresorptive medication after a fragility fracture. Rheumatology International 2017;37:875-882.
8. Sale JEM, Ashe MC, Beaton D, Bogoch E, Frankel L. Men’s health-seeking behaviours regarding bone health after a fragility fracture: A secondary analysis of qualitative data. Osteoporosis International 2016;27(10):3113-3119.
9. Sale JEM. An open letter to The BMJ editors on qualitative research. BMJ 2016;352:i563.
10. Sale JEM, Gignac MA, Hawker G, Beaton D, Frankel L, Bogoch E, Elliot-Gibson V. Patients do not have a consistent understanding of high risk for future fracture: A qualitative study of patients from a post-fracture secondary prevention program. Osteoporosis International 2016;27(1):65-73.
Click here for a full listing of Dr. Sale’s publications.